Jennifer Zachary has sold MRK and made no open-market buys since Nov 2022

Jennifer Zachary is the Executive Vice President and General Counsel at Merck & Co., Inc. (MRK), a position she has held since April 2018. In this role, she advises the board of directors and executives, leads the office of general counsel, sets global legal strategy, and oversees compliance, safety and environment, and security functions.( As a corporate insider, she has recently engaged in trading activities at MRK in her capacity as EVP and GC.[user query]

Prior to Merck, Jennifer Zachary was a partner at Covington & Burling LLP from 2011 to 2018, specializing in pharmaceutical and medical device regulatory law. Earlier, she served as Associate Chief Counsel for Enforcement at the U.S. Food and Drug Administration (2005-2011) and as a Special Assistant U.S. Attorney in the Civil Division of the U.S. Attorney’s Office for the District of Columbia. She holds a B.S. in biology and B.A. in chemistry from Arizona State University and a J.D. from Harvard Law School. Zachary serves on the boards of REGENXBIO Inc. (since 2022, including audit committee) and Code the Dream, and is a member of multiple bar associations.(

Written by Perplexity from public sources.